Vaccines for the prevention of diseases caused by potential bioweapons

被引:25
作者
Hassani, M
Patel, MC
Pirofski, LA
机构
[1] Albert Einstein Coll Med, Div Infect Dis, Dept Med, Bronx, NY 10461 USA
[2] Montefiore Med Ctr, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
关键词
bioterror; anthrax; smallpox; plague; tularemia; Q fever; viral hemorrhagic fever; vaccine; toxin; category A agents;
D O I
10.1016/j.clim.2003.09.010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The development of vaccines and implementation of vaccination programs are among the most important medical contributions to humanity. To date, vaccination has reduced morbidity and mortality from infectious diseases more than any other specific medical intervention. The intentional use of bioweapons against civilians (bioterrorism), recently highlighted by events around the world, has fueled interest in the development of vaccines for potential microbial agents of bioterror. This review discusses the microbial agents that are considered to pose the greatest risk to the public, the diseases associated with them, and the vaccines that are available for their prevention. The paucity of such vaccines and uncertainty regarding mechanisms of vaccine efficacy and the microbial antigens that elicit protection underscore the need for continued study of host-microbe interaction and the immune response to potential agents of bioterror for the development of new vaccines and immune-based therapies to combat their potential to harm the public. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 110 条
[1]  
Anderson A O, 1988, Adv Exp Med Biol, V237, P717
[2]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[3]   Smallpox vaccination in 2003: Key information for clinicians [J].
Bartlett, J ;
Borio, L ;
Radonovich, L ;
Mair, JS ;
O'Toole, T ;
Mair, M ;
Halsey, N ;
Grow, R ;
Inglesby, TV .
CLINICAL INFECTIOUS DISEASES, 2003, 36 (07) :883-902
[4]   Bioterrorism [J].
Bellamy, RJ ;
Freedman, AR .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 2001, 94 (04) :227-234
[5]   Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity [J].
Belyakov, IM ;
Moss, B ;
Strober, W ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (08) :4512-4517
[6]   Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in treating West Nile virus infection in mice [J].
Ben-Nathan, D ;
Lustig, S ;
Tam, G ;
Robinzon, S ;
Segal, S ;
Rager-Zisman, B .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (01) :5-12
[7]   Improved protection against Venezuelan equine encephalitis by genetic engineering of a recombinant vaccinia virus [J].
Bennett, AM ;
Lescott, T ;
Phillpotts, RJ .
VIRAL IMMUNOLOGY, 1998, 11 (03) :109-117
[8]   Hemorrhagic fever viruses as biological weapons - Medical and public health management [J].
Borio, L ;
Inglesby, T ;
Peters, CJ ;
Schmaljohn, AL ;
Hughes, JM ;
Jahrling, PB ;
Ksiazek, T ;
Johnson, KM ;
Meyerhoff, A ;
O'Toole, T ;
Ascher, MS ;
Bartlett, J ;
Breman, JG ;
Eitzen, EM ;
Hamburg, M ;
Hauer, J ;
Henderson, A ;
Johnson, RT ;
Kwik, G ;
Layton, M ;
Lillibridge, S ;
Nabel, GJ ;
Osterholm, MT ;
Perl, TM ;
Russell, P ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (18) :2391-2405
[9]   Active immunisation against human tick-borne diseases [J].
Bratu, S ;
Lutwick, LI .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (02) :187-195
[10]   Cidofovir protects mice against lethal aerosol or intranasal cowpox virus challenge [J].
Bray, M ;
Martinez, M ;
Smee, DF ;
Kefauver, D ;
Thompson, E ;
Huggins, JW .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :10-19